“Commissioning of this API facility will help Senores broaden its offerings and strengthen its competitiveness in the Regulated Markets, especially in the CDMO/CMO business.” Swapnil Shah, Managing Director, Senores Pharmaceuticals Limited
Senores Pharmaceuticals Limited (‘Senores’ or ‘SPL’) has recently inaugurated and commenced manufacturing activities at its greenfield Active Pharmaceutical Ingredient (‘API’) plant located at Mehsana in Gujarat. Spread across approximately 230,000 sq. ft. with an installed capacity of ~100 Metric Tons per Annum, this is Senores’ second API manufacturing facility, adding significantly to the existing API manufacturing capabilities.
Commenting on the inauguration, Swapnil Shah, Managing Director, Senores Pharmaceuticals Limited said, “We are delighted to commence operations at our greenfield state-of-the-art API facility at Mehsana. Commissioning of this API facility will help Senores broaden its offerings and strengthen its competitiveness in the Regulated Markets, especially in the CDMO/CMO business.”
